Table 5. Demographic data and virus detection frequencies in patients according to adenoid sizes.
| Clinical feature/virus detection | 0–50% | 50–75% | 75–100% |
| Patients (N) | 15 (10.08) | 58 (48.74) | 46 (38.66) |
| Females | 4 (26.66) | 31 (55.5) | 22 (47.82) |
| Age (mean in years) * | 7.0 | 6.31 | 5.26 |
| All Viruses + | 15(100) | 56 (96.55) | 46 (100) |
| virus co-infections + | 11 (73.33) | 35 (60.34) | 35 (76.08) |
| Virus + in adenoids * | 11 (73.3) | 48 (82.75) | 43 (93.47) |
| Virus co-infections in adenoids | 5 (33.33) | 21 (36.20) | 27 (58.69) |
| HAdV + | 7 (46.66) | 28 (48.27) | 21(45.65) |
| HAdV + isolated | 1 (6.66) | 2 (3.44) | 2 (4.34) |
| HAdV + in adenoids | 7 (46.66) | 24 (41.38) | 20 (43.47) |
| HAdV + isolated in adenoids | 4 (26.66) | 7 (12.06) | 3 (6.52) |
| HBoV + | 4(26.66) | 17 (29.31) | 15 (32.60) |
| HBoV + isolated | 0 (0) | 2 (3.44) | 0 (0) |
| HBoV + in adenoids | 3 (20.0) | 13 (22.41) | 12 (26.08) |
| HBoV + isolated in adenoids | 0 (0) | 2 (3.44) | 1 (2.17) |
| HRV + | 8 (53.33) | 22 (37.93) | 16 (34.78) |
| HRV + isolated | 3 (20.0) | 5 (8.62) | 2 (4.34) |
| HRV + in adenoids | 3 (20.0) | 17 (29.31) | 10 (21.74) |
| HRV + isolated in adenoids | 1 (6.66) | 7 (12.06) | 2 (4.34) |
| HEV + | 7 (46.66) | 21 (36.20) | 21 (45.65) |
| HEV + isolated | 0 (0) | 8 (13.79) | 5 (10.87) |
| HEV + in adenoids | 3 (20.0) | 15 (25.86) | 19 (41.30) |
| HEV + isolated in adenoids | 0 (0) | 9 (15.51) | 5 (10.87) |
| HRSV + | 2 (13.33) | 7 (12.06) | 9 (19.56) |
| HRSV + isolated | 0 (0) | 1 (1.72) | 1 (2.17) |
| HRSV + in adenoids | 0 (0) | 6 (10.34) | 8 (17.39) |
| HRSV + isolated in adenoids | 0 (0) | 1 (1.72) | 3 (6.52) |
| HMPV + | 4 (26.66) | 7 (12.06) | 10 (21.74) |
| HMPV + isolated | 0 (0) | 2 (3.44) | 1 (2.17) |
| HMPV + in adenoids | 2 (13.33) | 1 (1.72) | 7 (15.21) |
| HMPV + isolated in adenoids | 1 (6.66) | 0 (0) | 1 (2.17) |
| FLU + | 1 (6.66) | 5 (8.62) | 1 (2.17) |
| FLU + isolated | 0 (0) | 1 (1.72) | 0 (0) |
| FLU + in adenoids | 0 (0) | 3 (5.17) | 0 (0) |
| FLU + isolated in adenoids | 0 (0) | 1 (1.72) | 0 (0) |
| HPIV + | 2 (13.33) | 1 (1.72) | 3 (6.52) |
| HPIV + isolated | 0 (0) | 0 (0) | 0 (0) |
| HPIV + in adenoids | 1 (6.66) | 1 (1.72) | 2 (4.34) |
| HPIV + isolated in adenoids | 0 (0) | 0 (0) | 0 (0) |
| HCoV + | 0 (0) | 1 (1.72) | 3 (6.52) |
| HCoV + isolated | 0 (0) | 0 (0) | 0 (0) |
| HCoV + in adenoids | 0 (0) | 1 (1.72) | 3 (6.52) |
| HCoV + isolated in adenoids | 0 (0) | 0 (0) | 1 (2.17) |
*
p≤0.05.
Obs: Adenoids were not available from two patients.